Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

Capstan Medical announced its first in-human cardiac valve replacements using its catheter-based robotic surgical platform.

Capstan CEO Maggie Nixon discusses first-in-human feedback, the all-at-once approach, regulatory strategy and the tricuspid ...

Buoyed by $110m in funding three months ago, Capstan Medical has reported the first-in-human cases with the mitral technology ...

"Today marks a pivotal moment in the evolution of structural heart therapy," Capstan Medical CEO Maggie Nixon said.

Today, there are more than 7 million people in the U.S. with heart valve disease ... robotic platform provided unprecedented catheter stability and control, achieving optimal implant positioning.

Medical device designers often use these three terms to describe the trends driving their current and future product development. Of these requisites, smaller has become a fixation for next-generation ...